Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | PRCP | P42785 | 4/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 10/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 10/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10202513 | 0.95 | KCNH2 (0.46) | KCNH2PRCPHCRTR1HCRTR2CYP1A2 | |
| SCHEMBL10201814 | 0.95 | PRCP (0.38) | KCNH2PRCPHCRTR1HCRTR2 | |
| SCHEMBL10201558 | 0.92 | HCRTR1 (0.41) | HCRTR1HCRTR2 | |
| SCHEMBL12374131 | 0.90 | KCNH2 (0.49) | KCNH2HCRTR1HCRTR2CYP1A2CYP3A4 | |
| SCHEMBL10202512 | 0.89 | HCRTR1 (0.40) | PRCPHCRTR1HCRTR2 | |
| SCHEMBL12374143 | 0.89 | PRCP (0.38) | KCNH2PRCPHCRTR1HCRTR2 | |
| SCHEMBL10202511 | 0.88 | HCRTR1 (0.39) | HCRTR1HCRTR2 | |
| SCHEMBL10202423 | 0.88 | HCRTR1 (0.43) | KCNH2PRCPHCRTR1HCRTR2CYP1A2 | |
| SCHEMBL2276767 | 0.87 | KCNH2 (0.48) | KCNH2PRCPCYP1A2CYP3A4CYP2D6 | |
| SCHEMBL2278820 | 0.87 | KCNH2 (0.48) | KCNH2PRCPCYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012018325-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-02-09 | — | — | WO | disclosed |